Lin said that it costs about $2 billion to develop a drug in the private sector, while NIH-funded research produces a drug at ...

Miscommunication between hospital staff regularly puts patients at risk, a new study says. Poor communications between health ...

“Poor communication is a substantial cause of patient safety incidents,” concluded the research team led by Jeremy Howick, a ...

Trials are used to test potential medicines, treatments or procedures. The National Institutes for Health define a clinical ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

HUTCHMED (China) Limited ("HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer ...

The Federal Ministry of Health considers the proven safety problems to have been resolved. The objection rate remains at ...

Driving habits can be a surprising window into our personalities. Psychologists agree that the way we drive can actually say ...

Mariella Frostrup revealed she had heart disease and was 'on medication you inject twice a year' saying it was 'a life-saver ...

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic ...

Use of psilocybin, the hallucinogenic chemical found in what is known as "magic mushrooms," has increased significantly nationwide since 2019 ...